Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Name: Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Published: 2015
License: Public Domain

Novartis Pharmaceuticals · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

visual impairment due to diabetic macular edema, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Related documents